Exhibit 99.2

                   Ibis Technology Names Charles M.
                  McKenna as Chief Operating Officer

   DANVERS, Mass.--(BUSINESS WIRE)--July 20, 2005--Ibis Technology
Corporation (Nasdaq NM: IBIS), a leading provider of SIMOX-SOI
implantation equipment to the worldwide semiconductor industry, today
announced the appointment of Charles M. McKenna as executive vice
president and chief operating officer, effective today. McKenna will
report directly to Martin J. Reid, Ibis' president and CEO, and will
be responsible for managing the company's worldwide engineering,
production and sales and marketing operations.
    McKenna has over thirty years experience in the semiconductor
equipment industry, including positions with Varian Semiconductor
Equipment Associates where he served as chief operating officer and
chief technical officer, and Brooks Automation where he was executive
vice president and chief technology officer. Earlier, McKenna held
various management and engineering positions at IBM, and Hughes
Research Lab.
    Martin J. Reid, president and CEO of Ibis Technology Corporation,
said, "We are very pleased to have Chuck McKenna join Ibis in this
important, senior management role. Chuck has a wide range of executive
management skills, and the timing of his joining Ibis couldn't be
better. We value Chuck's ability to contribute to the management of
the strategic planning process necessary to build highly productive
teams that can efficiently respond to future customer demand. In
addition, his extensive experience with ion implant system
architectures and processes and his leadership skills will help Ibis
refine its product roadmaps, enabling us to deliver the kind of
technical innovation and operational excellence demanded by our wafer
manufacturer customers."
    "The breadth and depth of Chuck's long-term relationships with
semiconductor industry leaders and his international experience will
also be a great asset for Ibis," added Reid.
    "Ibis is at an important juncture in its growth," said McKenna. "I
believe the timing is right to drive SIMOX into mainstream SOI wafer
production, and I look forward to working with this outstanding team
of people to respond to the growing market needs for cost-effective
SOI solutions."
    McKenna, who has served as a special project consultant at Ibis
since May of this year, holds a bachelor's degree in physics from St.
Joseph's College and a Ph.D. in nuclear physics from Florida State
University.
    In a separate press release issued by Ibis today, the company
reported its second quarter 2005 financial results.

    About Ibis Technology

    Ibis Technology Corporation is a leading provider of oxygen
implanters for the production of SIMOX-SOI
(Separation-by-Implantation-of-Oxygen Silicon-On-Insulator) wafers for
the worldwide semiconductor industry. Headquartered in Danvers,
Massachusetts, the company maintains an additional office in Aptos,
California. Ibis Technology is traded on the Nasdaq National Market
under the symbol IBIS. Information about Ibis Technology Corporation
and SIMOX-SOI is available on Ibis' web site at www.ibis.com.

    "Safe Harbor" Statement under the Private Securities Litigation
Reform Act of 1995

    This release contains express or implied forward-looking
statements regarding, among other things, (i) customer interest in and
demand for, and market acceptance of, the company's SIMOX-SOI
technology, (ii) the company's ability to conduct its operations in a
manner consistent with its current plan and existing capital resources
or otherwise to obtain additional implanter orders or to secure
financing to continue as a going concern, (iii) the company's
expectations regarding future orders for i2000 implanters, (iv) the
adequacy of the company's cash resources for continuing and future
operations, and (v) the adoption rate of SOI technology. Such
statements are neither promises nor guarantees, but rather are subject
to risks and uncertainties which could cause actual results to differ
materially from those described in the forward-looking statements.
Such risks and uncertainties include, but are not limited to,
cessation as a going concern due to the depletion of the company's
cash reserves at an unanticipated rate combined with an inability to
obtain customer orders or to secure financing, future continued
migration to SOI technology and market acceptance of SIMOX, the level
of demand for the company's products, the company's ability to pursue
and maintain further strategic relationships, partnerships and
alliances with third parties, the company's ability to protect its
proprietary technology, the potential trends in the semiconductor
industry generally, the ease with which the i2000 can be installed and
qualified in fabrication facilities, the likelihood that implanters,
if ordered, will be qualified and accepted by customers without
substantial delay, modification, or cancellation, in whole or in part,
the likelihood and timing of revenue recognition on such transactions,
the impact of competitive products, technologies and pricing, the
impact of rapidly changing technology, the possibility of further
asset impairment and resulting charges, equipment capacity and supply
constraints or difficulties, the company's limited history in selling
implanters, general economic conditions, and other risks and
uncertainties described in the company's Securities and Exchange
Commission filings from time to time, including but not limited to,
the company's Annual Report on Form 10-K for the year ended December
31, 2004. All information set forth in this press release is as of
July 20, 2005, and Ibis undertakes no duty to update this information
unless required by law.


    CONTACT: Company Contact:
             Ibis Technology Corporation
             William J. Schmidt, 978-777-4247
             Chief Financial Officer
             or
             IR Agency Contact:
             Bill Monigle Associates
             Bill Monigle, 603-424-1184
             President